Sunesis Pharmaceuticals' Series B Round

Sunesis Pharmaceuticals raised a round of funding on December 17, 1999.

Sunesis is an oncology company developing cell-cycle inhibitors with a method of discovering drugs in pieces, or fragments. This Tethering is a process whereby the fragment is built out using the targ…

Articles about Sunesis Pharmaceuticals' Series B Round: